Health system execs eyeing AI investments, but lack vendor knowledge


Adoption and investment in artificial intelligence and robotic process automation is still in its early growth stage in the healthcare industry, with just half of hospital leaders familiar with the technologies. WHY IT MATTERS These were among the results of a survey of 115 executives at hospital systems and independent hospitals in the United States, conducted by healthcare digitization vendor Olive and market research firm Sage Growth Partners. The study also found that nearly a quarter (23 percent) of health system executives are looking to invest in the two technologies today, and half said they plan to do so within the next two years. The top reasons cited for deploying AI technology included improving efficiency and reducing costs, improving the quality of care and improving patient satisfaction and engagement. While interest in AI and RPA technology is growing, the survey results also indicated that there is a lack of general knowledge as to where to procure the solutions or what vendors offer them, with more than half of survey respondents unable to name an AI or RPA vendor or solution.